Prognostic impact of 18 F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer.
Hye Lim ParkSea-Won LeeJi Hyung HongJieun LeeAhwon LeeSoo Jin KwonSonya Youngju ParkIe Ryung YooPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
Metabolic parameters derived from preoperative PET/CT was significantly associated with recurrence in stage II IDC primarily treated with surgery. PET/CT can be a powerful prognostic tool in conjunction with novel staging systems and current biomarkers for patients undergoing contemporary therapy. Our results urge to reconsider the currently underestimated value of PET/CT confined to diagnostic aspect and to newly recognize its prognostic impact in these intermediate-risk breast cancer.